Peripheral Neuropathy Trial, Recruiting (NCT04791449)

Peripheral Neuropathy Trial, Recruiting NCT04791449 Sponsor: University of New Mexico Condition: Peripheral Neuropathy

Printed from Voxsanity (voxsanity.com.au) — NCT04791449 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Neuropathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with type 2 diabetes
You are between 20 and 80 years old
Your blood flow to your feet is at an acceptable level, measured by specific tests on your ankle, arm, or toe (confirm with trial site)
You have had a blood sugar test within the last 12 weeks showing a result between 100–350 mg/dL
You have had a long-term blood sugar average test (HbA1c) within the last 12 weeks showing a result below 14%
You have a diabetic foot ulcer that is rated at a mild to moderate severity level (confirm with trial site)
You can read and speak English or Spanish

Who may not be able to join:

You are not able to give your own consent to participate in the study
You are unable to get approval from a doctor or medical professional to take part
You do not have a reliable way to travel to the University of New Mexico Hospital (UNMH) for visits
You currently have an infection anywhere in your body
You have had an organ or tissue transplant, or your immune system is weakened for any reason
You are currently incarcerated (in prison)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 13 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Eric J Lew, DPM, University of New Mexico Health Sciences Center

Phone: 505-272-4107

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04791449

Sponsor: University of New Mexico

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Neuropathy

Trial contact: 505-272-4107

More information: https://clinicaltrials.gov/study/NCT04791449

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with type 2 diabetes
You are between 20 and 80 years old
Your blood flow to your feet is at an acceptable level, measured by specific tests on your ankle, arm, or toe (confirm with trial site)
You have had a blood sugar test within the last 12 weeks showing a result between 100–350 mg/dL
You have had a long-term blood sugar average test (HbA1c) within the last 12 weeks showing a result below 14%
You have a diabetic foot ulcer that is rated at a mild to moderate severity level (confirm with trial site)
You can read and speak English or Spanish

Who may not be able to join:

You are not able to give your own consent to participate in the study
You are unable to get approval from a doctor or medical professional to take part
You do not have a reliable way to travel to the University of New Mexico Hospital (UNMH) for visits
You currently have an infection anywhere in your body
You have had an organ or tissue transplant, or your immune system is weakened for any reason
You are currently incarcerated (in prison)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 13 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of New Mexico

Registry

ClinicalTrials.gov

Start date

10 October 2021

Est. completion

31 May 2035

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

wound healing time

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov